mustofa, syazili (2019) Decreased plasma epidermal growth factor (EGF) levels in patients with severe chronic obstructive pulmonary disease. Pneumologia, 68 (1). pp. 21-26. ISSN 2247-059X

[img] Text
[2247059X - Pneumologia] Decreased plasma epidermal growth factor (EGF) levels in patients with severe chronic obstructive pulmonary disease.pdf

Download (326kB)
Official URL: https://content.sciendo.com/configurable/contentpa...

Abstract

Abstract Background: Chronic mucus hypersecretion is a common feature in chronic obstructive pulmonary disease (COPD) and is associated with epidermal growth factor (EGF) activity. Aberrant EGF and its receptor signalling can cause airway hyperproliferation, increase in mucous cell differentiation and mucus hyperproduction. Furthermore, it can also promote subepithelial fibrosis and excessive collagen deposition in COPD. The objective of this research was to investigate the plasma levels of EGF in smokers with COPD in comparison with clinically healthy smokers. In addition, the relationship between the plasma levels of EGF and clinical features was investigated. Methods: A cross-sectional study included 82 clinically stable male patients with mild-to-very severe COPD (mean age: 64.5±8.6 years), and the control group consisted of 86 healthy male smokers (mean age: 61.6±9.5 years). To define COPD, we performed spirometry and classified COPD using Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification. We analyzed the levels of EGF by enzyme-linked immunosorbent assay in plasma. Results: The mean serum levels of EGF were significantly lower in smokers with COPD than those in controls (69.30 and 83.82 pg/mL, respectively, p = 0.046). The plasma levels of EGF were significantly different (p = 0.004) between mild COPD and moderate-to-very severe COPD. There were no significant differences between the levels of EGF in plasma of spontaneous sputum producers (COPD patients) vs. nonsputum producers (p = 0.101) and between nonexacerbated COPD and exacerbated COPD patients(p = 0.138). Conclusions: There is a significant difference in the plasma levels of EGF in male smokers with COPD as compared with male healthy smokers. Our findings suggest that the plasma levels of EGF may contribute to the pathogenesis of COPD. Keywords: COPD; plasma levels of EGF; smokers; mucous hypersecretion; exacerbation; spirometry

Item Type: Article
Subjects: R Medicine > R Medicine (General)
Divisions: Fakultas Kedokteran (FK) > Prodi Pendidikan Dokter
Depositing User: dr Syazili Mustofa
Date Deposited: 04 Nov 2019 02:26
Last Modified: 04 Nov 2019 02:26
URI: http://repository.lppm.unila.ac.id/id/eprint/14343

Actions (login required)

View Item View Item